REGENXBIO Inc.
RGNX
Cena:
$ 6.35
-0.40 (-5.93%)
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK INC. | 8.6 mil | 18.83% | 0.00% | 0.00% | 2015-12-31 |
| BLACKROCK, INC. | 5.8 mil | 11.21% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 5.5 mil | 10.76% | 0.00% | 0.00% | 2024-09-30 |
| REDMILE GROUP, LLC | 4.4 mil | 8.47% | -2.21% | 2.42% | 2017-03-31 |
| JPMORGAN CHASE & CO | 3.5 mil | 6.76% | 0.00% | 0.00% | 2015-09-30 |
| VANGUARD GROUP INC | 3.4 mil | 6.53% | 0.00% | 0.00% | 2015-09-30 |
| STATE STREET CORP | 2.7 mil | 5.30% | 0.00% | 0.00% | 2015-12-31 |
| MORGAN STANLEY | 2.1 mil | 4.01% | 0.00% | 0.00% | 2015-09-30 |
| GOLDMAN SACHS GROUP INC | 1.8 mil | 3.57% | 0.00% | 0.00% | 2016-06-30 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.5 mil | 2.91% | -0.26% | 0.60% | 2023-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.3 mil | 2.54% | 0.01% | 0.01% | 2023-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1 mil | 2.21% | 0.00% | 0.00% | 2015-12-31 |
| AQR CAPITAL MANAGEMENT LLC | 1.1 mil | 2.04% | -0.01% | 0.00% | 2022-03-31 |
| 1.0 mil | 1.98% | 0.00% | 0.00% | 2026-03-31 | |
| DIMENSIONAL FUND ADVISORS LP | 1.0 mil | 1.96% | 0.00% | 0.00% | 2018-06-30 |
| ASSENAGON ASSET MANAGEMENT S.A. | 980.61 tis | 1.90% | -0.01% | 0.01% | 2023-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 797.10 tis | 1.55% | -0.01% | 0.01% | 2022-12-31 |
| BIOIMPACT CAPITAL LLC | 557.08 tis | 1.22% | -0.85% | 1.01% | 2022-09-30 |
| NUVEEN, LLC | 582.02 tis | 1.13% | 0.00% | 0.00% | 2025-03-31 |
| TWO SIGMA INVESTMENTS, LP | 554.89 tis | 1.08% | 0.00% | 0.00% | 2023-09-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500.00 tis | 0.98% | 0.01% | 0.01% | 2024-12-31 |
| PALE FIRE CAPITAL SE | 493.73 tis | 0.96% | -0.12% | 0.36% | 2024-12-31 |
| 22NW, LP | 492.76 tis | 0.96% | -2.77% | 2.83% | 2025-03-31 |
| NORGES BANK | 449.40 tis | 0.88% | 0.00% | 0.00% | 2024-12-31 |
| INVENOMIC CAPITAL MANAGEMENT LP | 426.90 tis | 0.83% | 0.20% | 0.20% | 2025-09-30 |
| SONIC GP LLC | 403.08 tis | 0.79% | -2.80% | 6.87% | 2022-12-31 |
| JEFFERIES FINANCIAL GROUP INC. | 400.00 tis | 0.79% | 0.04% | 0.04% | 2024-09-30 |
| PERCEPTIVE ADVISORS LLC | 342.41 tis | 0.78% | 0.14% | 0.14% | 2023-12-31 |
| NORTHERN TRUST CORP | 393.64 tis | 0.76% | 0.00% | 0.00% | 2015-12-31 |
| STIFEL FINANCIAL CORP | 392.77 tis | 0.76% | 0.00% | 0.00% | 2021-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 390.60 tis | 0.76% | 0.00% | 0.00% | 2015-12-31 |
| ACADIAN ASSET MANAGEMENT LLC | 375.40 tis | 0.73% | 0.00% | 0.01% | 2024-06-30 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 357.79 tis | 0.70% | 0.00% | 0.02% | 2018-03-31 |
| RTW INVESTMENTS, LP | 350.00 tis | 0.69% | -0.01% | 0.04% | 2024-03-31 |
| HRT FINANCIAL LP | 351.49 tis | 0.68% | -0.01% | 0.01% | 2024-09-30 |
| BANK OF AMERICA CORP /DE/ | 324.86 tis | 0.63% | 0.00% | 0.00% | 2015-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 312.06 tis | 0.61% | 0.00% | 0.00% | 2026-03-31 |
| FMR LLC | 311.27 tis | 0.60% | 0.00% | 0.00% | 2015-09-30 |
| RENAISSANCE TECHNOLOGIES LLC | 305.29 tis | 0.59% | 0.00% | 0.00% | 2024-12-31 |
| WS MANAGEMENT LLLP | 300.00 tis | 0.59% | -0.11% | 0.22% | 2018-03-31 |
| VOSS CAPITAL, LLC | 295.79 tis | 0.57% | -0.07% | 0.13% | 2024-12-31 |
| CITADEL ADVISORS LLC | 291.87 tis | 0.57% | 0.00% | 0.00% | 2016-09-30 |
| SIREN, L.L.C. | 284.00 tis | 0.56% | -0.05% | 0.10% | 2024-09-30 |
| D. E. SHAW & CO., INC. | 286.00 tis | 0.55% | 0.00% | 0.00% | 2025-12-31 |
| MILLENNIUM MANAGEMENT LLC | 285.17 tis | 0.55% | 0.00% | 0.00% | 2019-06-30 |
| ARTAL GROUP S.A. | 250.00 tis | 0.55% | -0.06% | 0.07% | 2024-03-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 235.96 tis | 0.54% | 0.02% | 0.02% | 2023-12-31 |
| Y-INTERCEPT (HONG KONG) LTD | 275.02 tis | 0.53% | 0.04% | 0.04% | 2026-03-31 |
| AQUILO CAPITAL MANAGEMENT, LLC | 271.30 tis | 0.53% | -0.56% | 3.48% | 2019-12-31 |
| GSK PLC | 271.46 tis | 0.53% | -0.11% | 0.38% | 2025-12-31 |
| GHOST TREE CAPITAL, LLC | 265.00 tis | 0.52% | 0.22% | 0.84% | 2024-03-31 |
| AVIDITY PARTNERS MANAGEMENT LP | 260.00 tis | 0.51% | -0.05% | 0.35% | 2024-03-31 |
| UBS GROUP AG | 257.46 tis | 0.50% | 0.00% | 0.00% | 2016-12-31 |
| TREXQUANT INVESTMENT LP | 250.70 tis | 0.49% | 0.01% | 0.03% | 2022-12-31 |
| GSA CAPITAL PARTNERS LLP | 226.58 tis | 0.44% | 0.05% | 0.13% | 2024-06-30 |
| EXOME ASSET MANAGEMENT LLC | 226.06 tis | 0.44% | -1.37% | 1.17% | 2025-03-31 |
| MARSHALL WACE, LLP | 222.34 tis | 0.43% | 0.00% | 0.00% | 2025-03-31 |
| ARCHPOINT INVESTORS | 222.28 tis | 0.43% | -0.32% | 0.44% | 2017-03-31 |
| PANAGORA ASSET MANAGEMENT INC | 222.72 tis | 0.43% | 0.00% | 0.01% | 2023-03-31 |
| JUMP FINANCIAL, LLC | 220.79 tis | 0.43% | -0.01% | 0.02% | 2023-06-30 |
| PRINCIPAL FINANCIAL GROUP INC | 214.35 tis | 0.42% | 0.00% | 0.00% | 2018-06-30 |
| SQUAREPOINT OPS LLC | 206.41 tis | 0.40% | 0.00% | 0.00% | 2023-09-30 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 170.22 tis | 0.39% | 0.00% | 0.01% | 2019-09-30 |
| AMERIPRISE FINANCIAL INC | 200.35 tis | 0.39% | 0.00% | 0.00% | 2018-06-30 |
| PROSIGHT MANAGEMENT, LP | 200.00 tis | 0.39% | 0.27% | 0.27% | 2026-03-31 |
| MOORE CAPITAL MANAGEMENT, LP | 200.00 tis | 0.39% | 0.02% | 0.04% | 2024-03-31 |
| DEUTSCHE BANK AG\ | 196.97 tis | 0.38% | 0.00% | 0.00% | 2015-09-30 |
| JANE STREET GROUP, LLC | 196.52 tis | 0.38% | 0.00% | 0.00% | 2020-09-30 |
| MAN GROUP PLC | 187.63 tis | 0.36% | 0.00% | 0.00% | 2024-09-30 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 186.60 tis | 0.36% | -0.01% | 0.02% | 2025-09-30 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 180.00 tis | 0.35% | 0.00% | 0.01% | 2019-09-30 |
| WOODLINE PARTNERS LP | 146.33 tis | 0.33% | 0.03% | 0.03% | 2024-03-31 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 152.44 tis | 0.33% | -0.02% | 0.01% | 2022-03-31 |
| BARCLAYS PLC | 164.42 tis | 0.32% | 0.00% | 0.00% | 2016-09-30 |
| INVESCO LTD. | 158.83 tis | 0.31% | 0.00% | 0.00% | 2015-09-30 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 155.89 tis | 0.30% | 0.09% | 0.09% | 2025-03-31 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 151.29 tis | 0.29% | 0.11% | 0.11% | 2025-06-30 |
| MACQUARIE GROUP LTD | 149.00 tis | 0.29% | 0.00% | 0.00% | 2018-03-31 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 149.00 tis | 0.29% | 0.00% | 0.00% | 2025-12-31 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 144.85 tis | 0.28% | -0.03% | 0.15% | 2024-03-31 |
| BANK OF NEW YORK MELLON CORP | 140.22 tis | 0.27% | 0.00% | 0.00% | 2015-12-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 139.79 tis | 0.27% | 0.00% | 0.00% | 2025-12-31 |
| IEQ CAPITAL, LLC | 139.64 tis | 0.27% | 0.00% | 0.01% | 2025-03-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 132.00 tis | 0.26% | 0.00% | 0.00% | 2024-06-30 |
| AFFINITY ASSET ADVISORS, LLC | 110.00 tis | 0.25% | 0.29% | 0.29% | 2024-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 124.63 tis | 0.25% | 0.01% | 0.01% | 2024-03-31 |
| TWO SIGMA ADVISERS, LP | 124.90 tis | 0.24% | 0.00% | 0.00% | 2023-12-31 |
| LEGAL & GENERAL GROUP PLC | 121.62 tis | 0.24% | 0.00% | 0.00% | 2016-06-30 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 103.07 tis | 0.24% | 0.10% | 0.10% | 2024-03-31 |
| ROYCE & ASSOCIATES LP | 119.04 tis | 0.23% | 0.02% | 0.02% | 2025-12-31 |
| RHUMBLINE ADVISERS | 115.03 tis | 0.23% | 0.00% | 0.00% | 2016-06-30 |
| PROPEL BIO MANAGEMENT, LLC | 116.90 tis | 0.23% | 1.44% | 1.44% | 2025-12-31 |
| CITIGROUP INC | 114.81 tis | 0.23% | 0.00% | 0.00% | 2015-12-31 |
| RAFFERTY ASSET MANAGEMENT, LLC | 103.19 tis | 0.23% | -0.01% | 0.00% | 2019-03-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 115.44 tis | 0.22% | 0.00% | 0.01% | 2025-12-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 112.32 tis | 0.22% | 0.00% | 0.00% | 2019-06-30 |
| RUSSELL INVESTMENTS GROUP, LTD. | 113.43 tis | 0.22% | 0.00% | 0.00% | 2025-06-30 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 112.52 tis | 0.22% | 0.06% | 0.06% | 2025-03-31 |
| AMERICAN CENTURY COMPANIES INC | 113.13 tis | 0.22% | 0.00% | 0.00% | 2022-03-31 |
| STATE OF WISCONSIN INVESTMENT BOARD | 112.05 tis | 0.22% | 0.00% | 0.00% | 2017-06-30 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 112.01 tis | 0.22% | 0.00% | 0.00% | 2025-06-30 |
| XTX TOPCO LTD | 108.12 tis | 0.21% | 0.06% | 0.07% | 2023-09-30 |
| VESTAL POINT CAPITAL, LP | 108.53 tis | 0.21% | 0.01% | 0.03% | 2025-12-31 |
| ALLIANZ ASSET MANAGEMENT GMBH | 92.60 tis | 0.20% | 0.00% | 0.00% | 2024-06-30 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 100.45 tis | 0.20% | 0.00% | 0.00% | 2024-06-30 |
| WINTON GROUP LTD | 96.94 tis | 0.19% | 0.01% | 0.07% | 2024-03-31 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 96.48 tis | 0.19% | 0.00% | 0.01% | 2018-06-30 |
| RAYMOND JAMES FINANCIAL INC | 95.28 tis | 0.19% | 0.00% | 0.00% | 2024-12-31 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 93.92 tis | 0.18% | 0.00% | 0.05% | 2021-06-30 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 92.62 tis | 0.18% | 0.00% | 0.00% | 2025-06-30 |
| SWISS NATIONAL BANK | 81.50 tis | 0.18% | 0.00% | 0.00% | 2016-12-31 |
| DEKABANK DEUTSCHE GIROZENTRALE | 74.60 tis | 0.16% | 0.00% | 0.00% | 2020-09-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 70.96 tis | 0.16% | 0.00% | 0.00% | 2018-06-30 |
| BNP PARIBAS ARBITRAGE, SNC | 67.76 tis | 0.15% | 0.00% | 0.00% | 2019-09-30 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 62.44 tis | 0.14% | 0.00% | 0.00% | 2021-03-31 |
| PRUDENTIAL FINANCIAL INC | 51.37 tis | 0.11% | 0.00% | 0.00% | 2017-12-31 |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 45.13 tis | 0.10% | 0.00% | 0.00% | 2018-06-30 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 44.39 tis | 0.10% | 0.00% | 0.00% | 2016-12-31 |
| QUEST PARTNERS LLC | 42.00 tis | 0.09% | 0.07% | 0.07% | 2024-03-31 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 41.11 tis | 0.09% | 0.00% | 0.00% | 2015-12-31 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 40.96 tis | 0.09% | 0.00% | 0.00% | 2020-09-30 |
| VOYA INVESTMENT MANAGEMENT LLC | 39.40 tis | 0.09% | 0.00% | 0.00% | 2017-06-30 |
| THRIVENT FINANCIAL FOR LUTHERANS | 37.62 tis | 0.08% | 0.00% | 0.00% | 2018-06-30 |
| RAYMOND JAMES & ASSOCIATES | 37.23 tis | 0.08% | 0.00% | 0.00% | 2018-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| PAKOLA STEVE | officer: Chief Medical Officer | S-Sale | 15309 | 11.02 | 13.5 2026 | 232617 |
| PAKOLA STEVE | officer: Chief Medical Officer | S-Sale | 5124 | 10.35 | 12.3 2026 | 247926 |
| PAKOLA STEVE | officer: Chief Medical Officer | F-InKind | 5267 | 11.16 | 3.2 2026 | 253050 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | F-InKind | 4700 | 11.16 | 3.2 2026 | 210667 |
| Mills Kenneth T. | director | M-Exempt | 225000 | 13.09 | 29.1 2026 | 225000 |
| Mills Kenneth T. | director | F-InKind | 221753 | 13.41 | 29.1 2026 | 486118 |
| Mills Kenneth T. | director | M-Exempt | 225000 | 13.09 | 29.1 2026 | 707871 |
| Chan Mitchell | officer: Chief Financial Officer | A-Award | 39650 | 14.18 | 8.1 2026 | 39650 |
| Chan Mitchell | officer: Chief Financial Officer | A-Award | 73749 | 0.00 | 8.1 2026 | 127717 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | A-Award | 39650 | 14.18 | 8.1 2026 | 39650 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | A-Award | 73749 | 0.00 | 8.1 2026 | 215367 |
| Simpson Curran | director, officer: Chief Executive Officer | A-Award | 233651 | 14.18 | 8.1 2026 | 233651 |
| Simpson Curran | director, officer: Chief Executive Officer | A-Award | 144864 | 0.00 | 8.1 2026 | 342467 |
| Malzahn Craig | officer: Chief Technology Officer | A-Award | 35402 | 14.18 | 8.1 2026 | 35402 |
| Malzahn Craig | officer: Chief Technology Officer | A-Award | 65847 | 0.00 | 8.1 2026 | 82194 |
| PAKOLA STEVE | officer: Chief Medical Officer | A-Award | 35402 | 14.18 | 8.1 2026 | 35402 |
| PAKOLA STEVE | officer: Chief Medical Officer | A-Award | 65847 | 0.00 | 8.1 2026 | 258317 |
| PAKOLA STEVE | officer: Chief Medical Officer | F-InKind | 18247 | 14.40 | 6.1 2026 | 192470 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | F-InKind | 9793 | 14.40 | 6.1 2026 | 141618 |
| Malzahn Craig | officer: Chief Technology Officer | F-InKind | 1238 | 14.40 | 6.1 2026 | 16347 |
| Simpson Curran | director, officer: Chief Executive Officer | F-InKind | 18559 | 14.40 | 6.1 2026 | 197603 |
| Simpson Curran | director, officer: Chief Executive Officer | S-Sale | 20811 | 12.62 | 10.10 2025 | 216162 |
| Simpson Curran | director, officer: Chief Executive Officer | S-Sale | 7624 | 10.03 | 1.10 2025 | 236973 |
| Simpson Curran | director, officer: Chief Executive Officer | S-Sale | 7734 | 10.02 | 12.9 2025 | 244597 |
| Chan Mitchell | officer: Chief Financial Officer | F-InKind | 4901 | 8.93 | 3.9 2025 | 53968 |
| Malzahn Craig | officer: Chief Technology Officer | F-InKind | 234 | 8.93 | 3.9 2025 | 17585 |
| Christmas Patrick J. | officer: Chief Strategy & Legal Officer | F-InKind | 4699 | 8.19 | 4.8 2025 | 151411 |
| Simpson Curran | director, officer: Chief Executive Officer | F-InKind | 4701 | 8.23 | 3.7 2025 | 252331 |
| Bennett Jean | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| Bennett Jean | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| KARABELAS ARGERIS N | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| KARABELAS ARGERIS N | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Glucksmann Alexandra | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| Glucksmann Alexandra | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| MIGAUSKY GEORGE V | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| MIGAUSKY GEORGE V | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Mills Kenneth T. | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Mills Kenneth T. | director | A-Award | 7768 | 0.00 | 3.6 2025 | 482871 |
| STUMP DAVID C | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| STUMP DAVID C | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Tasse Daniel | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| Tasse Daniel | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Zachary Jennifer | director | A-Award | 7768 | 0.00 | 3.6 2025 | 22064 |
| Zachary Jennifer | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Fox Allan M. | director | A-Award | 7768 | 0.00 | 3.6 2025 | 19054 |
| Fox Allan M. | director | A-Award | 39815 | 8.85 | 3.6 2025 | 39815 |
| Mills Kenneth T. | director | M-Exempt | 20602 | 3.76 | 14.5 2025 | 0 |
| Mills Kenneth T. | director | S-Sale | 20602 | 7.91 | 14.5 2025 | 475103 |
| Mills Kenneth T. | director | M-Exempt | 20602 | 3.76 | 14.5 2025 | 495705 |
| Danos Olivier | officer: Chief Scientific Officer | F-InKind | 5452 | 8.07 | 4.4 2025 | 226348 |
| PAKOLA STEVE | officer: Chief Medical Officer | F-InKind | 5263 | 8.07 | 4.4 2025 | 210717 |
| Christmas Patrick J. | officer: Chief Legal Officer | F-InKind | 4700 | 8.07 | 4.4 2025 | 156110 |
| Mills Kenneth T. | director | M-Exempt | 30752 | 3.76 | 31.3 2025 | 20602 |
| Mills Kenneth T. | director | M-Exempt | 30752 | 3.76 | 31.3 2025 | 475103 |
| Malzahn Craig | officer: Chief Technology Officer | 9600 | 34.31 | 24.3 2025 | 0 | |
| Malzahn Craig | officer: Chief Technology Officer | 9600 | 44.97 | 24.3 2025 | 0 | |
| Malzahn Craig | officer: Chief Technology Officer | 33150 | 7.86 | 24.3 2025 | 0 | |
| Malzahn Craig | officer: Chief Technology Officer | 19130 | 22.25 | 24.3 2025 | 0 | |
| Malzahn Craig | officer: Chief Technology Officer | 31200 | 40.68 | 24.3 2025 | 0 | |
| Malzahn Craig | officer: Chief Technology Officer | 12750 | 18.34 | 24.3 2025 | 0 | |
| Malzahn Craig | officer: Chief Technology Officer | 0 | 0.00 | 24.3 2025 | 17819 | |
| Simpson Curran | director, officer: Chief Executive Officer | A-Award | 478606 | 7.86 | 14.1 2025 | 478606 |
| Christmas Patrick J. | officer: Chief Legal Officer | F-InKind | 11395 | 7.73 | 6.1 2025 | 160810 |
| Christmas Patrick J. | officer: Chief Legal Officer | A-Award | 223350 | 7.86 | 6.1 2025 | 223350 |
| Chan Mitchell | officer: Chief Financial Officer | A-Award | 62547 | 7.86 | 6.1 2025 | 62547 |
| Simpson Curran | director, officer: Chief Executive Officer | F-InKind | 11917 | 7.73 | 6.1 2025 | 158120 |
| Simpson Curran | director, officer: Chief Executive Officer | A-Award | 98912 | 0.00 | 6.1 2025 | 257032 |
| Simpson Curran | director, officer: Chief Executive Officer | A-Award | 476606 | 7.86 | 6.1 2025 | 476606 |
| Danos Olivier | officer: Chief Scientific Officer | A-Award | 95721 | 7.86 | 6.1 2025 | 95721 |
| Danos Olivier | officer: Chief Scientific Officer | F-InKind | 12630 | 7.73 | 6.1 2025 | 172453 |
| Danos Olivier | officer: Chief Scientific Officer | A-Award | 59347 | 0.00 | 6.1 2025 | 231800 |
| PAKOLA STEVE | officer: Chief Medical Officer | A-Award | 103698 | 7.86 | 6.1 2025 | 103698 |
| PAKOLA STEVE | officer: Chief Medical Officer | F-InKind | 13891 | 7.73 | 6.1 2025 | 151687 |
| PAKOLA STEVE | officer: Chief Medical Officer | A-Award | 64293 | 0.00 | 6.1 2025 | 215980 |
| KARABELAS ARGERIS N | director | M-Exempt | 10000 | 3.76 | 2.10 2024 | 0 |
| KARABELAS ARGERIS N | director | S-Sale | 10000 | 10.11 | 2.10 2024 | 11286 |
| KARABELAS ARGERIS N | director | M-Exempt | 10000 | 3.76 | 2.10 2024 | 21286 |
| Chan Mitchell | 0 | 0.00 | 18.9 2024 | 0 | ||
| Chan Mitchell | officer: Chief Financial Officer | A-Award | 58869 | 0.00 | 18.9 2024 | 58869 |
| Chan Mitchell | officer: Chief Financial Officer | A-Award | 289362 | 12.74 | 18.9 2024 | 289362 |
| KARABELAS ARGERIS N | director | M-Exempt | 10000 | 3.76 | 4.9 2024 | 10000 |
| KARABELAS ARGERIS N | director | S-Sale | 700 | 12.34 | 4.9 2024 | 11286 |
| KARABELAS ARGERIS N | director | S-Sale | 9300 | 11.50 | 4.9 2024 | 11986 |
| KARABELAS ARGERIS N | director | M-Exempt | 10000 | 3.76 | 4.9 2024 | 21286 |
| Mills Kenneth T. | director | M-Exempt | 36316 | 0.85 | 12.8 2024 | 0 |
| Mills Kenneth T. | director | M-Exempt | 36316 | 0.85 | 12.8 2024 | 444351 |
| Danos Olivier | officer: Chief Scientific Officer | A-Award | 1363 | 9.95 | 5.8 2024 | 126216 |
| Danos Olivier | officer: Chief Scientific Officer | A-Award | 58867 | 0.00 | 5.8 2024 | 185083 |
| Simpson Curran | director, officer: Chief Executive Officer | S-Sale | 100 | 15.00 | 5.8 2024 | 170037 |
| KARABELAS ARGERIS N | director | M-Exempt | 100 | 12.74 | 5.8 2024 | 1400 |
| KARABELAS ARGERIS N | director | S-Sale | 100 | 15.00 | 5.8 2024 | 11286 |
| KARABELAS ARGERIS N | director | S-Sale | 400 | 14.59 | 5.8 2024 | 11386 |
| KARABELAS ARGERIS N | director | S-Sale | 9600 | 13.45 | 5.8 2024 | 11786 |
| KARABELAS ARGERIS N | director | M-Exempt | 10000 | 3.76 | 5.8 2024 | 20000 |
| KARABELAS ARGERIS N | director | M-Exempt | 10000 | 3.76 | 5.8 2024 | 21286 |
| KARABELAS ARGERIS N | director | M-Exempt | 100 | 12.74 | 5.8 2024 | 21386 |
| Christmas Patrick J. | officer: Chief Legal Officer | A-Award | 56446 | 0.00 | 5.8 2024 | 172205 |
| PAKOLA STEVE | officer: Chief Medical Officer | A-Award | 58386 | 0.00 | 5.8 2024 | 165578 |
| KARABELAS ARGERIS N | director | S-Sale | 11000 | 15.05 | 30.7 2024 | 11286 |
| KARABELAS ARGERIS N | director | M-Exempt | 11000 | 12.74 | 30.7 2024 | 22286 |
